Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» The Medicines Company
The Medicines Company
Novartis Is Looking for Deals. Are These 3 Biotechs on Its List?
Motley Fool
Mon, 05/2/22 - 11:57 am
Novartis
M&A
AveXis
Zolgensma
Endocyte
Pluvicto
The Medicines Company
Levqio
Pharmacquired: Splashy deals belie a shallow pool of heart drugs left to acquire
BioPharma Dive
Thu, 10/8/20 - 11:16 pm
M&A
cardiology
Bristol-Myers Squibb
MyoKardia
Novartis
The Medicines Company
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
M&A
Bristol-Myers Squibb
Celgene
AbbVie
Allergan
Roche
Spark Therapeutics
Novartis
The Medicines Company
Alkermes
Rodin Therapeutics
Sumitomo Dainippon
Roivant
Novartis buys Medicines Co. in $9.7B bet on cholesterol drug
Biopharma Dive
Sun, 11/24/19 - 11:38 pm
Novartis
The Medicines Company
M&A
Amidst Novartis Takeover Rumors, The Medicines Company Announces Positive Cholesterol Data
BioSpace
Tue, 11/19/19 - 11:32 pm
The Medicines Company
Novartis
M&A
inclisiran
clinical trials
Novartis eyes Medicines Co to boost cardio franchise - report
Yahoo/Reuters
Tue, 11/19/19 - 10:18 am
Novartis
The Medicines Company
cardiovascular disease
M&A
AHA: MedCo's PCSK9 rival inclisiran hits LDL
Fierce Biotech
Mon, 11/18/19 - 09:53 am
AHA
The Medicines Company
inclisiran
The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down
Yahoo/Benzinga
Sun, 11/17/19 - 08:47 pm
AHA
The Medicines Company
Intrexon
Alnylam
Pieris
Roche
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
Xconomy
Wed, 09/25/19 - 11:53 am
The Medicines Company
clinical trials
inclisiran
cholesterol
Medicines Co. awaits its date with destiny
Biopharma Dive
Thu, 08/1/19 - 11:05 am
The Medicines Company
clinical trials
inclisiran
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Forbes
Mon, 06/10/19 - 10:31 am
The Medicines Company
Amgen
Sanofi
Regeneron
inclisiran
PCSK9 inhibitors
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
Xconomy
Mon, 05/20/19 - 09:41 am
The Medicines Company
Alnylam
inclisiran
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sat, 05/11/19 - 12:31 pm
biotech
Achillion
Sesen Bio
The Medicines Company
Amgen
Daiichi Sankyo
earnings
Here's Why Shares of The Medicines Company Sank 14.5% Today
Motley Fool
Thu, 12/13/18 - 09:01 pm
The Medicines Company
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
Xconomy
Mon, 10/22/18 - 10:11 am
Qpex Biopharma
The Medicines Company
drug-resistant bacteria
The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale
Fierce Pharma
Wed, 11/29/17 - 10:15 am
The Medicines Company
PCSK9 inhibitors
inclisiran
Vabomere
The Medicines Company PCSK9 Inhibitor Strategy: More Heart Patients Via Lower Pricing
Forbes
Thu, 11/9/17 - 10:09 am
The Medicines Company
PCSK9 inhibitors
drug pricing
inclisiran
New antibiotic therapies: what future?
GoinPharma
Mon, 10/23/17 - 10:00 pm
antibiotics
Merck
Paratek
Tetraphase Pharmaceuticals
Motif Biosciences
The Medicines Company
Data in hand, The Medicines Co. speeds PCSK9 plans
BioPharma Dive
Wed, 11/16/16 - 10:09 am
The Medicines Company
PCSK9 inhibitors
inclisiran
Despite Promising Early Data, The New Cholesterol Lowering Drug - PCSK9si - Has Significant Hurdles
Forbes
Thu, 10/20/16 - 09:12 am
PCSK9 inhibitors
PCSK9si
The Medicines Company
Pages
1
2
next ›
last »